| Report Title | Price | Action |
|---|---|---|
| Potassium Transporting ATPase Alpha Chain 1 (Gastric H(+)/K(+) ATPase Subunit Alpha or Proton Pump or ATP4A or EC 7.2.2.19) - Drugs in Development, 2021
Potassium Transporting ATPase Alpha Chain 1 (Gastric H(+)/K(+) ATPase Subunit Alpha or Proton Pump or ATP4A or EC 7.2.2.19) - Drugs in Development, 20...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) - Drugs in Development, 2021
Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) - Drugs in Development, 2021 Summary Cycl...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Subacute Necrotizing Encephalomyelopathy (Leigh Disease) (Genetic Disorders) - Drugs in Development, 2021
Subacute Necrotizing Encephalomyelopathy (Leigh Disease) (Genetic Disorders) - Drugs in Development, 2021 Summary Subacute Necrotizing Encephalomyel...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Prostaglandin F2 Alpha Receptor (Prostanoid FP Receptor or PTGFR) - Drugs in Development, 2021
Prostaglandin F2 Alpha Receptor (Prostanoid FP Receptor or PTGFR) - Drugs in Development, 2021 Summary Prostaglandin F2 Alpha Receptor (Prostanoid F...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4.3.3) - Drugs in Development, 2021
D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4.3.3) - Drugs in Development, 2021 Summary D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4....
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021
Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021 Summary Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Protein Kinase B (PKB or AKT or EC 2.7.11.1) - Drugs in Development, 2021
Protein Kinase B (PKB or AKT or EC 2.7.11.1) - Drugs in Development, 2021 Summary Protein Kinase B (PKB or AKT or EC 2.7.11.1) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Diacylglycerol O Acyltransferase 2 (Diglyceride Acyltransferase 2 or Acyl CoA Retinol O Fatty Acyltransferase or DGAT2 or EC 2.3.1.76 or EC 2.3.1.20) - Drugs in Development, 2021
Diacylglycerol O Acyltransferase 2 (Diglyceride Acyltransferase 2 or Acyl CoA Retinol O Fatty Acyltransferase or DGAT2 or EC 2.3.1.76 or EC 2.3.1.20) ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021
Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021 Summary Cryptococcal Meningitis (Infectious Disease) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Sodium Channel Protein Type 1 Subunit Alpha (Sodium Channel Protein Brain I Subunit Alpha or Voltage Gated Sodium Channel Subunit Alpha Nav1.1 or SCN1A) - Drugs in Development, 2021
Sodium Channel Protein Type 1 Subunit Alpha (Sodium Channel Protein Brain I Subunit Alpha or Voltage Gated Sodium Channel Subunit Alpha Nav1.1 or SCN1...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| DNA Repair Protein RAD51 Homolog 1 (RAD51 Homolog A or RAD51) - Drugs in Development, 2021
DNA Repair Protein RAD51 Homolog 1 (RAD51 Homolog A or RAD51) - Drugs in Development, 2021 Summary DNA Repair Protein RAD51 Homolog 1 (RAD51 Homolog...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| HSV-2 (Infectious Disease) - Drugs in Development, 2021
HSV-2 (Infectious Disease) - Drugs in Development, 2021 Summary HSV-2 (Infectious Disease) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Alpha 1 Adrenergic Receptor (ADRA1) - Drugs in Development, 2021
Alpha 1 Adrenergic Receptor (ADRA1) - Drugs in Development, 2021 Summary Alpha 1 Adrenergic Receptor (ADRA1) - Drugs in Development, 2021 provides i...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Enoyl [Acyl Carrier Protein] Reductase [NADH] (FAS-II Enoyl ACP Reductase or NADH Dependent 2-Trans-Enoyl ACP Reductase or inhA or EC 1.3.1.9) - Drugs in Development, 2021
Enoyl [Acyl Carrier Protein] Reductase [NADH] (FAS-II Enoyl ACP Reductase or NADH Dependent 2-Trans-Enoyl ACP Reductase or inhA or EC 1.3.1.9) - Drugs...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Systemic Candidiasis (Infectious Disease) - Drugs in Development, 2021
Systemic Candidiasis (Infectious Disease) - Drugs in Development, 2021 Summary Systemic Candidiasis (Infectious Disease) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) - Drugs in Development, 2021
Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) - Drugs in Development, 2021 Summary Alpha 1 Antitrypsin (Alp...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3 (PRKR Like Endoplasmic Reticulum Kinase or Pancreatic eIF2 Alpha Kinase or EIF2AK3 or EC 2.7.11.1) - Drugs in Development, 2021
Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3 (PRKR Like Endoplasmic Reticulum Kinase or Pancreatic eIF2 Alpha Kinase or EIF2AK3 or EC 2.7...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Periodontal Disease (Mouth and Dental Disorders) - Drugs in Development, 2021
Periodontal Disease (Mouth and Dental Disorders) - Drugs in Development, 2021 Summary Periodontal Disease (Mouth and Dental Disorders) - Drugs in De...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Cells Expressing Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Drugs in Development, 2021
Cells Expressing Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Excitatory Amino Acid Transporter 2 (Glutamate/Aspartate Transporter II or Sodium Dependent Glutamate/Aspartate Transporter 2 or Solute Carrier Family 1 Member 2 or SLC1A2) - Drugs in Development, 2021
Excitatory Amino Acid Transporter 2 (Glutamate/Aspartate Transporter II or Sodium Dependent Glutamate/Aspartate Transporter 2 or Solute Carrier Family...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 |